Meyka AI API is live for developers.Start building.
Advertisement
Hisamitsu Pharmaceutical Co., Inc.

Hisamitsu Pharmaceutical Co., Inc. (HTSUF) Stock Overview

Explore Hisamitsu Pharmaceutical Co., Inc.’s financial performance, market position, analyst ratings, and future outlook.

HTSUF●PNK
HealthcareDrug Manufacturers - Specialty & Generic
$29.00
$0.00(0.00%)
U.S. Market opens in 49h 8m
Advertisement

Hisamitsu Pharmaceutical Co., Inc. (HTSUF)

Meyka AI Score

Z

Key Financials

Market Cap2B
P/E Ratio17.14
EPS (TTM)$1.73
ROE0.07%
Fundamental Analysis

AI Price Forecasts

1 Month$27.93
3 Months$27.80
1 Year Target$27.83

HTSUF Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hisamitsu Pharmaceutical Co., Inc. (HTSUF) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 0.00, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $27.83.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 17.14 and a market capitalization of 2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
-10.22%
3-Year Change
0.76%
5-Year Change
-52.46%
All-Time (Max) Change
6.42%

Contact Information

https://www.hisamitsu.co.jp
81 3 5293 1720
408, Tashiro Daikan-machi, Tosu, NaN, 841-0017

Company Facts

27,590 Employees
IPO DateSep 23, 2010
CountryJP

Frequently Asked Questions